The Biotech Growth Trust (LON:BIOG) Shares Cross Below 50-Day Moving Average – Should You Sell?

Shares of The Biotech Growth Trust PLC (LON:BIOG) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 886.16 ($11.03) and traded as low as GBX 875 ($10.89). The Biotech Growth Trust shares last traded at GBX 881 ($10.97), with a volume of 164,870 shares traded.

The Biotech Growth Trust Stock Performance

The company has a market capitalization of £283.39 million, a price-to-earnings ratio of 426.09 and a beta of 0.50. The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00. The stock has a 50 day simple moving average of GBX 886.16 and a two-hundred day simple moving average of GBX 971.53.

The Biotech Growth Trust (LON:BIOG) last posted its earnings results on Wednesday, November 27th. The company reported GBX 0.20 ($0.00) EPS for the quarter. The Biotech Growth Trust had a net margin of 92.85% and a return on equity of 21.57%.

Insider Activity

In other news, insider Nicola Shepherd acquired 1,000 shares of the company’s stock in a transaction on Monday, January 13th. The shares were bought at an average cost of GBX 846 ($10.53) per share, with a total value of £8,460 ($10,532.87). Also, insider Hamish Baillie bought 3,000 shares of the stock in a transaction dated Wednesday, November 27th. The stock was purchased at an average cost of GBX 931 ($11.59) per share, for a total transaction of £27,930 ($34,773.41). Over the last ninety days, insiders bought 6,222 shares of company stock valued at $5,659,584. 0.71% of the stock is currently owned by company insiders.

About The Biotech Growth Trust

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).